在基本血栓细胞血症中,JAK2V617F突变和循环的细胞外囊泡
Mohamed Hussam Aswad1,2, Jarmila Kissova1,2, Petra Ovesna3
1Department of Clinical Hematology, Faculty of Medicine, University Hospital Brno, Brno, Czech Republic.
Clinical hemorheology and microcirculation
|June 19, 2023
概括
患有JAK2V617F突变的基本血栓塞瘤 (ET) 患者面临更高的血栓形成风险. 血小板细胞外囊泡 (EVs) 的增加与这种突变有关,这表明在ET相关的凝血中发挥了作用.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 基本血小板血 (ET) 是一种由血小板性并发症特征的骨髓增殖性新生体,影响患者的死亡率.
- 已知JAK2V617F突变是ET中血栓形成的独立风险因素.
- 细胞外囊泡 (EVs) 正在成为骨髓增殖性瘤和血栓形成的潜在生物标志物.
研究的目的:
- 研究JAK2V617F突变与细胞外囊泡 (EV) 水平在患有基本血小板血 (ET) 的患者之间的关系.
- 评估JAK2V617F突变状态与ET患者血栓形成风险之间的关联.
主要方法:
- 对119名ET患者的分析,以评估循环中的细胞外囊泡 (EV) 水平.
- 统计分析以确定与JAK2V617F突变相关的血栓形成风险.
- 在ET患者和健康个体之间比较EV水平和促凝剂活性.
主要成果:
- 在诊断前和随访期间,JAK2V617F阳性ET患者的血栓形成风险显著增加.
- 与健康对照组相比,ET患者表现出较高的血小板-EV,红细胞-EV和EV的前凝活性.
- 在存在JAK2V617F突变时,血小板-EV的绝对和相对计数显著增加.
结论:
- JAK2V617F突变是基本血栓细胞血症中血栓形成的独立风险因素.
- 患有JAK2V617F突变的ET患者血小板-EV水平升高表明,血栓形成的病原发生有作用.
- 这些发现支持JAK2V617F驱动的血小板激活机制,有助于ET的血栓形成.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Extrinsic and Intrinsic Pathways of Hemostasis
8.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.4K


